Effect of atorvastatin on impaired vascular function in healthy old men

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 2, 2004, Pages 157-164

  Weverling Rijnsburger, A W E ^a   Blauw, G J ^a   Meinders, A E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 hydroxytryptamine; Acetylcholine; Cholesterol; Endothelial function; Sodium nitroprusside; Statins; Very old

Indexed keywords

ACETYLCHOLINE; ATORVASTATIN; ENDOTHELIUM DERIVED RELAXING FACTOR; NITROPRUSSIDE SODIUM; SEROTONIN;

AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SYMPTOMATOLOGY; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTICHOLESTEREMIC AGENTS; BRACHIAL ARTERY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; FOREARM; HEPTANOIC ACIDS; HUMANS; MALE; NITROPRUSSIDE; PLETHYSMOGRAPHY; PYRROLES; REFERENCE VALUES; REGIONAL BLOOD FLOW; SEROTONIN; TRIGLYCERIDES; VASODILATION; VASODILATOR AGENTS;

EID: 1842734390     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00548.x     Document Type: Article

References (41)

1. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG (1997) Total cholesterol and risk of mortality in the oldest old. Lancet, 350, 1119-1123.
2. Shipley MJ, Pocock SJ, Marmot MG (1991) Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. British Medical Journal, 303, 89-92.
3. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet, 358, 351-355.
4. Shepherd J, Blauw GJ, Murphy MB et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360, 1623-1630.
5. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. (2002) Lancet, 360, 7-22.
6. Vaughan CJ, Murphy MB, Buckley BM (1996) Statins do more than just lower cholesterol. Lancet, 348, 1079-1082.
7. Davignon J, Laaksonen R (1999) Low-density lipoprotein-independent effects of statins. Current Opinion in Lipidology, 10, 543-559.
8. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101, 1899-1906.
9. Neunteufl T, Priglinger U, Heher S et al. (2000) Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. Journal of the American College of Cardiology, 35, 277-283.
10. Kiowski W, Linder L, Stoschitzky K et al (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation, 90, 27-34.
11. Celermajer DS, Sorensen KE, Georgakopoulos D et al. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation, 88, 2149-2155.
12. McVeigh GE, Lemay L, Morgan D, Cohn JN (1996) Effects of long-term cigarette smoking on endothelium-dependent responses in humans. American Journal of Cardiology, 78, 668-672.
13. Taddei S, Virdis A, Mattei P et al. (1995) Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation, 91, 1981-1987.
14. de Man FH, Weverling-Rijnsburger AW, Van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. (2000) Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 744-750.
15. Cockcroft JR, Wilkinson IB, Webb DJ and The Trevor Howell Lecture (1997) Age, arterial stiffness and the endothelium. Age and Ageing, 26(Suppl. 4), 53-60.
16. Gerhard M, Roddy MA, Creager SJ, Creager MA (1996) Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension, 27, 849-853.
17. Taddei S, Galetta F, Virdis A et al. (2000) Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation, 101, 2896-2901.
18. Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F (1998) Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. Journal of the American College of Cardiology, 32, 711-716.
19. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ (1995) Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet, 346, 467-471.
20. John S, Schmieder RE (2000) Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. Journal of Hypertension, 18, 363-374.
21. John S, Schlaich M, Langenfeld M et al. (1998) Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation, 98, 211-216.
22. Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW (1999) Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. Journal of the American College of Cardiology, 33, 234-241.
23. Kamper AM, de Craen AJ, Blauw GJ (2001) Forearm blood flow measurements using computerized R-wave triggered strain-gauge venous occlusion plethysmography: unilateral vs. bilateral measurements. Clinical Physiology, 21, 524-527.
24. Chang PC, Verlinde R, Bruning T, van Brummelen P (1988) A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm. Computers in Biology and Medicine, 18, 157-163.
25. Blauw GJ, van Brummelen P, Chang PC, Vermeij P, van Zwieten PA (1989) Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related. Journal of Cardiovascular Pharmacology, 14, 14-21.
26. Blauw GJ, van Brummelen P, Chang PC, Vermeij P, van Zwieten PA (1988) Regional vascular effects of serotonin and ketanserin in young, healthy subjects. Hypertension, 11, 256-263.
27. Bruning TA, Chang PC, Kemme MJ, Vermeij P, Pfaffendorf M, van Zwieten PA (1996) Comparison of cholinergic vasodilator responses to acetylcholine and methacholine in the human forearm. Blood Pressure, 5, 333-341.
28. Woo KS, McCrohon JA, Chook P et al. (1997) Chinese adults are less susceptible than whites to age-related endothelial dysfunction. Journal of the American College of Cardiology, 30, 113-118.
29. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. Journal of the American College of Cardiology, 24, 471-476.
30. Ignarro LJ (1989) Endothelium-derived nitric oxide: actions and properties. The FASEB Journal, 3, 31-36.
31. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
32. Bruning TA, Hendriks MG, Chang PC, Kuypers EA, van Zwieten PA (1994) In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circulation Research, 74, 912-919.
33. Ross G, Chaudhuri G, Ignarro LJ, Chyu KY (1991) Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide. European Journal of Pharmacology, 195, 291-293.
34. Bruning TA, Chang PC, Blauw GJ, Vermeij P, van Zwieten PA (1993) Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor. Journal of Cardiovascular Pharmacology, 22, 44-51.
35. Blauw GJ, van Brummelen P, van Zwieten PA (1988) Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930. Life Sciences, 43, 1441-1449.
36. Kemme MJ, Bruning TA, Chang PC, van Zwieten PA (1995) Cholinergic receptor-mediated responses in the arteriolar and venous vascular beds of the human forearm. Blood Pressure, 4, 293-299.
37. Andrawis N, Jones DS, Abernethy DR (2000) Aging is associated with endothelial dysfunction in the human forearm vasculature. Journal of the American Geriatrics Society, 48, 193-198.
38. Taddei S, Virdis A, Ghiadoni L et al. (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension, 38, 274-279.
39. van de Ree MA, Huisman MV, de Man FH, van der Vijver JC, Meinders AE, Blauw GJ (2001) Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovascular Research, 52, 299-305.
40. O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation, 95, 1126-1131.
41. Vogel RA, Corretti MC, Plotnick GD (1996) Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. American Journal of Cardiology, 77, 37-40.